In 2020, Linus Health made a significant stride in the field of cognitive health by acquiring Digital Cognition Technologies, a company that pioneered the modernization of the long-standing pen-and-paper Clock Drawing Test for cognitive impairment. With the introduction of a digitized pen, this innovation enhanced sensitivity and paved the way for the fully iPad-based DCTclock™. Drawing on 10 years of research and development at prestigious institutions such as MIT and Lahey Hospital & Medical Center, Linus Health’s DCTclock™ represents a quick and sensitive digital cognitive assessment that generates new insights from the drawing process itself, not just the final outputs. Building on its origins in drawing-based tests, Linus Health has expanded its focus to deliver an expansive digital platform that couples objective cognitive tests with actionable guidance for both providers and patients.
Linus Health, a Massachusetts-based digital health company, is dedicated to transforming brain health for people around the world. By advancing the detection and treatment of cognitive and brain disorders through cutting-edge neuroscience, clinical expertise, and artificial intelligence, Linus Health envisions a future where individuals can lead longer, happier, and healthier lives with improved brain health. At the core of Linus Health’s offerings is its digital cognitive assessment platform, which provides a sensitive and practical means of enabling early detection of cognitive impairment. This platform not only empowers healthcare providers with actionable clinical guidance but also supports patients with personalized action plans, fostering a collaborative approach to brain health.
Linus Health takes pride in partnering with leading healthcare delivery, life sciences, and research organizations to accelerate proactive intervention and personalized brain care. By collaborating with these esteemed partners, Linus Health aims to drive meaningful advancements in the field of cognitive health and provide individuals with the care and support they need. In 2021, Linus Health secured $55 million in new funding, fueling the next phase of its growth and enabling the company to expand its reach and impact. With a dedicated team of 90+ individuals, Linus Health is at the forefront of advancing its mission. Collaborating across various disciplines, including neuroscience, data science, clinical research, and software development, the team at Linus Health is committed to delivering innovative solutions that transform brain health. By leveraging cutting-edge technologies and insights, Linus Health aims to revolutionize how cognitive impairment is detected, addressed, and treated.
Linus Health, a pioneering digital health company, is dedicated to helping unlock early detection of Alzheimer’s and other dementias. With a focus on transforming brain health, Linus Health has developed a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. By leveraging advanced technology, cutting-edge research, and a deep understanding of cognitive health, Linus Health is revolutionizing the field of cognitive assessment and empowering individuals and healthcare providers with the tools they need to detect and address cognitive disorders at an early stage.
At the heart of Linus Health’s solutions is its next-generation digital cognitive assessment platform. This innovative platform represents a significant advancement in the field of cognitive assessment, enabling earlier detection and intervention in brain health. By leveraging the power of digital technology, Linus Health’s platform provides a comprehensive and sensitive assessment of cognitive function. The platform goes beyond traditional pen-and-paper tests by incorporating interactive elements and utilizing advanced algorithms to generate valuable insights from the drawing process itself, not just the final outputs.
This enables healthcare providers to detect cognitive impairment at its early stages, facilitating timely interventions and the early detection of Alzheimer’s and other dementias is of paramount importance for effective treatment and management. By enabling earlier detection through its next-generation cognitive assessment platform, Linus Health empowers healthcare providers to intervene at the earliest stages of cognitive decline. This enables them to develop personalized treatment plans, provide support to patients and their families, and improve overall outcomes. Through early detection and intervention, individuals can receive the care and support they need to maintain cognitive function, enhance quality of life, and potentially slow the progression of cognitive disorders.
In summary, Linus Health is a trailblazer in the field of cognitive health, leveraging its expertise in neuroscience, clinical research, and artificial intelligence to transform brain health for individuals worldwide. With its innovative digital cognitive assessment platform, Linus Health enables early detection of cognitive impairment, provides actionable clinical guidance to healthcare providers, and supports patients with personalized action plans. Through strategic partnerships, substantial funding, and a dedicated team, Linus Health is poised to revolutionize the way cognitive disorders are detected, managed, and treated. By advancing the field of cognitive health, Linus Health is committed to creating a future where individuals can enjoy longer, happier, and healthier lives with improved brain health.